Skip to main content
Sanofi
Healthcare · Drug Manufacturers - General
Made on Aug 1, 2026
Price at call $43.08
6-month call Bull +19.0%
Target by Feb 2027 $51.25
Great value below $45.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change +19.0% to $51.25
Predicted High $51.25 at 6 months
Predicted Low $43.35 in 2 weeks

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Aug 1, 2026 1:02 am
Bull SNY trends higher to $51.25 (+19.0% from $43.08) by Feb 2027. dip-then-recover
ThesisSNY trades at a deep discount to composite fair value near $120 with a beat-and-raise cadence and defensive low-beta profile, but the fallen-angel narrative and neutral regime cap re-rating speed. Expect a gradual grind higher from the attractive-below-$45 zone, not a snap to fair value.
Invalidated ifA break below $40 on heavy volume or a pipeline/regulatory setback that resets the earnings trajectory would falsify this path.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $43.08 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Aug 1, 2026 $43.08 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 15, 2026 $40.56–$45.60 typical range · internal point $43.35 ±5.9% 6/10 Low beta anchors price near current in neutral tape
What actually happened: closed $43.71 on Aug 14, 2026 = +1.5% vs the call (predicted +0.6%)  ·  direction HIT (called flat, was flat)  ·  off by 0.8 pp  ·  accuracy 10/10  ·  typical range ±5.9%: inside the band  ·  S&P +4.0% over the same window — beat it
1 month Sep 1, 2026 $39.42–$46.74 typical range · internal point $43.90 ±8.5% 6/10 Value buyers accumulate below $45 threshold
2 months Oct 1, 2026 $45.10 +4.7% 5/10 Defensive bid strengthens into autumn risk-off
3 months Nov 1, 2026 $46.75 +8.5% 5/10 Q3 print continues beat cadence, narrative shifts
4 months Dec 1, 2026 $48.20 +11.9% 4/10 Year-end rotation into quality-value defensives
5 months Jan 1, 2027 $49.50 +14.9% 4/10 Fair-value gravity accelerates as sentiment thaws
6 months Feb 1, 2027 $51.25 +19.0% 3/10 Gradual re-rating toward mid-tier valuation anchor

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $72.31 (+67.8%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 1 degraded · 0 notes — follow the chain top-down (cause → effect).
  • Degraded
    [warning] Sector in contraction — demand weakening across the industry
    upstream:valuation-synthesis

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$43.08
Composite fair value$119.69
Signal-adjusted fair value$118.67
DCF fair value$127.93
Anchored-PE fair value$150.33
Buy-below (value lens)$45.00
Value net score+25
Value confidence6 / 10
Quality net score+6
Memo confidence7 / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 29.3%  3m 29.4%  6m 26.2%  
Daily σ (realism noise)1.9%
Beta vs S&P 500 1m -0.45  3m 0.19  5m 0.33  
Trailing 6-month return-6.8%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #271041f8fcd5

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 30, 2026 freshest SNY-20260730-175301-75fd
ext-forensic-memo Jul 30, 2026 freshest ext-SNY-20260730-182641-f7c4
ext-lens-quality Jul 30, 2026 freshest ext-SNY-20260730-182641-f7c4
ext-lens-sentiment Jul 30, 2026 freshest ext-SNY-20260730-182641-f7c4
ext-lens-value Jul 30, 2026 freshest ext-SNY-20260730-182641-f7c4
scenario-valuation Jul 30, 2026 freshest SNY-20260730-175301-75fd
valuation-synthesis Jul 31, 2026 freshest SNY-20260730-175301-75fd

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

4 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Aug 1, 2026 v0.6.0 Bull $43.08 $51.25 +19.0% Feb 2027 viewing
Jul 25, 2026 v0.6.0 Bull $43.36 $47.80 +10.2% Jan 2027 view
Jul 24, 2026 v0.6.0 Bear $43.36 $38.50 -11.2% Jan 2027 view
Jul 8, 2026 v0.3.0 Bull $42.98 $60.11 +39.9% Jan 2027 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.